Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-1,001,1607 Ethynyl derivatives
The present invention relates to compounds of formula I ##STR00001## wherein R.sup.1 is hydrogen, F or Cl; L is a bond or lower alkylene; R.sup.2 is...
US-1,001,1606 Imidazopyrazinones as PDE1 inhibitors
The present invention provides imidazopyrazinones as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative...
US-1,001,1605 Process for the preparation of triazolo[4,5-D] pyrimidine cyclopentane compounds
The present invention relates to a process for preparation of triazolo[4,5-d] pyrimidine cyclopentane compounds of formula (I), and pharmaceutically acceptable...
US-1,001,1604 Method of treatment using substituted imidazo[1,2b]pyridazine compounds
Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease, Typanosoma cruzi infection and osteolytic...
US-1,001,1603 Process for preparing a carbapenem antibiotic
A process for the preparation of a carbapenem, includes the step of treating a solution of a protected carbapenem with hydrogen gas in the presence of a...
US-1,001,1602 Immunological reagents and uses therefor
The present invention provides a ligand which binds to MR1 wherein said binding results in binding of the MR1 to MAIT cells.
US-1,001,1601 Substituted spirocyclic inhibitors of autotaxin
The present invention relates to compounds according to Formula 1 and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of...
US-1,001,1600 Methods and compositions for inhibition of Ras
Inhibitors of Ras protein, methods to modulate the activity of Ras protein, and methods of treatment of disorders mediated by Ras protein are provided. A method...
US-1,001,1599 Compounds and compositions as inhibitors of MEK
The present invention relates to compounds of formula I: ##STR00001## in which n, R.sub.1, R.sub.2, R.sub.3a, R.sub.4 and R.sub.5 are defined in the Summary of...
US-1,001,1598 Small molecules targeting repeat r(CGG) sequences
The invention provides a series of bioactive small molecules that target expanded r(CGG) repeats, termed r(CGG).sup.exp, that causes Fragile X-associated Tremor...
US-1,001,1597 Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the...
Disclosed are compounds, pharmaceutical compositions and methods for modulating aquaporin 9.
US-1,001,1596 2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyri- dines as BACE1 inhibitors
The present invention provides compounds of Formula I ##STR00001## for the treatment of neurodegenerative or cognitive diseases. The method further provides...
US-1,001,1595 Ethyldiamine orexin receptor antagonists
The present invention is directed to ethyldiamne compounds which are antagonists of orexin receptors. Such compounds are of the general structural formula I: ...
US-1,001,1594 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists
The present invention provides compounds of Formula (I): ##STR00001## wherein all variables are as defined in the specification, and compositions comprising...
US-1,001,1593 Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
This invention is directed to a compound of Formula I ##STR00001## or a pharmaceutically acceptable salt thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4...
US-1,001,1592 Polycyclic inhibitor of anaplastic lymphoma kinase
Disclosed is a polycyclic inhibitor of anaplastic lymphoma kinase as represented by Formula (I), or a pharmaceutically acceptable salt or stereoisomer thereof....
US-1,001,1591 Crystalline form of afatinib dimaleate
The present invention provides a crystalline Form I of afatinib dimaleate, its process for preparation and pharmaceutical composition thereof, and its use in...
US-1,001,1590 Crystalline forms of vilazodone hydrochloride and vilazodone free base
The present application relates to crystalline and amorphous Vilazodone hydrochloride. The present application further relates to amorphous solid dispersions of...
US-1,001,1589 Treatments for gastrointestinal conditions
Compounds for the treatment of bacterial and parasitic infections which are hybrid compounds of compounds having antibacterial or antiparasitic activity and...
US-1,001,1588 1,2-substituted cyclopentanes as orexin receptor antagonists
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, (I) wherein L, X, R.sup.a, R.sup.b, R.sup.1, R.sup.2 and...
US-1,001,1587 Multivalent ligands targeting VEGFR
Compounds that target vascular endothelial growth factor receptors for therapy and imaging are disclosed. Methods for making the compounds and detecting or...
US-1,001,1586 Heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by...
US-1,001,1585 Factor XIa inhibitors
The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said...
US-1,001,1584 Polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene) sulfonyl]pyridin-3-yl}methyl)-2-methylindol-1-yl]-acetic...
The invention relates to a polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene)sulfonyl]pyridin-3-yl}methyl)-2-methyli- ndol-1-yl]-acetic acid which is stable...
US-1,001,1583 Inhibitors of lysine specific demethylase-1
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic...
US-1,001,1582 Substituted delta-lactones and methods of preparing same
The invention relates to substituted delta-lactones as well as to processes for synthesizing them, e.g., using fatty acids as starting material.
US-1,001,1581 Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound
The invention provides processes for preparing intermediates useful for preparing compounds of the formula: ##STR00001## or a tautomer or salt thereof, where...
US-1,001,1580 Diastereoselective synthesis of (.+-.)-epianastrephin, (.+-.)-anastrephin and analogs thereof
A process for the synthesis of trans-fused .gamma.-lactones having Formula (IV) from substituted cyclic ketones having Formula (I). A diastereoselective...
US-1,001,1579 Oxidation process to produce a purified carboxylic acid product via solvent displacement and post oxidation
Disclosed is a process to produce a dry purified carboxylic acid product comprising furan-2,5-dicarboxylic acid (FDCA). The process comprises oxidizing at least...
US-1,001,1578 Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
Disclosed herein are methods and compositions comprising compounds capable of normalizing neuronal calcium dyshomeostasis. Also disclosed are methods comprising...
US-1,001,1577 Methods for producing 5-(halomethyl)furfural
The present disclosure provides methods to produce 5-(halomethyl)furfural, including 5-(chloromethyl)furfural, by acid-catalyzed conversion of C6 saccharides,...
US-1,001,1576 Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive...
The actinic ray-sensitive or radiation-sensitive resin composition includes a crosslinking agent having a polarity converting group and an alkali-soluble resin,...
US-1,001,1575 Method for fabricating titanium-containing silicon oxide material and application of the same
A method for fabricating a titanium-containing silicon oxide material and an application of the same are disclosed. The method needn't use a template but...
US-1,001,1574 Glutaminase inhibitors and method of use
Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that...
US-1,001,1573 Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use
A compound having the structure of Formula I, wherein A is a substituted or unsubstituted aryl or heteroaryl group, D is a substituted or unsubstituted 5- or...
US-1,001,1572 Monocyclic isoxazolines as inhibitors of cholesterol ester transfer protein
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, wherein D1, D2 and D3 are each N, CH, or substituted...
US-1,001,1571 Preparation method for aromatic heterocyclic compound used as selective JAK3 and/or JAK1 kinase inhibitor and...
An application of a compound having general formula (I) as JAK3 and/or JAK1 kinase and a preparation method for the compound.
US-1,001,1570 Nucleic acid binding dyes with improved safety
The invention provides compounds, including fluorescent nucleic acid dyes, and methods for use including nucleic acid detection. Further provided are kits,...
US-1,001,1569 Process for synthesizing oxidized lactam compounds
The invention provides a method for the synthesis of dehydrogenated lactam drugs of Formula I: ##STR00001##
US-1,001,1568 Cyclohexyl pyridine derivative
A problem of the present invention is to provide a new compound which has NK.sub.1 receptor antagonist activity, whose CYP3A4 inhibitory activity is reduced...
US-1,001,1567 Method for the synthesis of acrylate derivatives
The present invention provides an improved synthesis of a salt of acrylate derivatives. The synthesis generally includes the preparation of an ester or an amide...
US-1,001,1566 Compounds
The present specification provides a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof; a process for preparing such a...
US-1,001,1564 Mixed decyl mercaptans compositions and methods of making same
Compositions comprising branched C.sub.10 mercaptans selected from the group consisting of 5-methyl-1-mercapto-nonane, 3-propyl-1-mercapto-heptane,...
US-1,001,1563 Lithium styrene sulfonate
To provide a novel lithium styrene sulfonate which is capable of solving a problem of an increase of the production cost due to drying under atmospheric...
US-1,001,1562 Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses...
The present invention relates to long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled texture, and uses thereof. Said...
US-1,001,1561 Thickening/stabilizing agent and thickened/stabilized composition using the same
A compound that thickens and/or gelatinizes a fluid organic substance to a desired viscosity, or uniformly stabilizes a composition containing the fluid organic...
US-1,001,1560 Alternative process for the purification of an intermediate in the synthesis of non-ionic X-ray contrast agents
Alternative continuous downstream processes for the production of 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide ("Compound A") are...
US-1,001,1559 Preparation of chiral amides and amines
This invention provides a convenient method for converting oximes into enamides. The process does not require the use of metallic reagents. Accordingly, it...
US-1,001,1557 Method for producing biphenylamines from azobenzenes by ruthenium catalysis
The present invention relates to a novel method for preparing substituted biphenylamines.
US-1,001,1556 Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis
Provided herein are estolide base oils and oligomeric compounds prepared from processes that include cross metathesis. Exemplary processes include the...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.